Alaunos Therapeutics, Inc. Conversion of Stock, Amount Converted
Alaunos Therapeutics, Inc. (TCRT) reported Conversion of Stock, Amount Converted of $692.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2017-02-16
- Alaunos Therapeutics, Inc. conversion of stock, amount converted for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- Alaunos Therapeutics, Inc. conversion of stock, amount converted for the quarter ending 2014-09-30 was $630.00K, a 800.00% increase year-over-year.
- Alaunos Therapeutics, Inc. conversion of stock, amount converted for the quarter ending 2013-12-31 was $54.00K.
- Alaunos Therapeutics, Inc. conversion of stock, amount converted for the quarter ending 2013-09-30 was $70.00K.
- Alaunos Therapeutics, Inc. conversion of stock, amount converted for fiscal 2014 was $692.00K, a 253.06% increase from fiscal 2013.
- Alaunos Therapeutics, Inc. conversion of stock, amount converted for fiscal 2013 was $196.00K.
| Period end | Conversion of Stock, Amount Converted 3 month | Conversion of Stock, Amount Converted 6 month | Conversion of Stock, Amount Converted 9 month | Conversion of Stock, Amount Converted 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $630.00K derived: sum of 2 quarters · filed 2017-02-16 | $692.00K 10-K · filed 2017-02-16 | |
| 2014-09-30 | $630.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $692.00K 10-Q · filed 2015-11-02 | ||
| 2014-06-30 | $62.00K 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $124.00K derived: sum of 2 quarters · filed 2016-02-24 | $196.00K 10-K · filed 2016-02-24 | |
| 2013-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $142.00K 10-Q · filed 2014-10-30 | ||
| 2013-06-30 | $72.00K 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |